UBS Group’s UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share UPH.WS Stock Holding History

UBS Group’s Portfolio UPH.WS Stock Details UPH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,298	Closed	-$124	–	10398
2023 Q3	$124	Buy	+10,298	New	+$160	﹤0.01%	8834
2023 Q1	–	Sell	-4,600	Closed	-$46	–	10975
2022 Q4	$46	Buy	+4,600	New	+$205	﹤0.01%	10485
2022 Q2	–	Sell	-8,079	Closed	-$1K	–	11290
2022 Q1	$1K	Buy	8,079 +553	+7%	+$170	﹤0.01%	10022
2021 Q4	$2K	Buy	+7,526	New	+$2.77K	﹤0.01%	9870

Other funds holding UPH.WS

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

UBS Group's UPH.WS Position: Q4 2023 in Review

UBS Group sold out of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) in Q4 2023, closing a stake of 10,298 shares — an estimated $124 sold.

UBS Group first reported a position in UPH.WS in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q4 2021. 1 fund tracked by Wall St. Rank holds UPH.WS as of Q4 2023.

UBS Group reported no remaining UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position as of Q4 2023 after selling out during the quarter.
UBS Group sold 10,298 UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share shares in Q4 2023, an estimated $124.
UBS Group first reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in Q4 2021 and held it in 4 quarters.
UBS Group's UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position peaked at $2K in Q4 2021.
1 fund tracked by Wall St. Rank held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.